Cancer research
Researchers in Shanghai, China, have discovered that human mesenchymal stem cells (MSCs) can be engineered to produce interleukin-12 (IL-12), a potent anti-tumor agent, to reduce the growth of renal cell carcinoma (RCC) in a mouse xenograft model. The study, published in Cancer Letters, demonstrated that systemically administered MSCs/IL-12 significantly
Cancer research
A novel approach to treating metastatic melanoma, T cell receptor (TCR) gene therapy, has been studied extensively in both clinical and preclinical settings. While adoptive T cell therapy (ACT) remains the best treatment option for metastatic melanoma, its limitations in availability and generation of therapeutic T cells for a larger
Cancer treatment
A compound isolated from the golden berry, Physalis peruviana, has been found to inhibit the growth of human lung cancer cells through DNA damage, apoptosis, and G2/M arrest. The study, published in BMC Cancer, demonstrates that the compound, 4beta-Hydroxywithanolide E (4betaHWE), has potential as a chemotherapeutic agent against lung
Cancer treatment
Researchers at the University of KwaZulu-Natal in Durban, South Africa, have made a significant discovery in the field of cancer research. Studying small cell lung cancer (SCLC), an aggressive tumor type that often leads to ectopic ACTH syndrome, the team found that over-expression of the glucocorticoid receptor (GR) promotes apoptosis
Cancer treatment
Researchers from Tianjin University in the People's Republic of China have developed a novel co-delivery system that significantly improves the cytotoxicity of 5-fluorouracil (5-FU) and enhances the apoptosis of human glioblastoma cells. The system utilizes poly(amidoamine) (PAMAM) dendrimer to co-deliver antisense-miR-21 oligonucleotide (as-miR-21) and 5-FU to human
Cancer research
Researchers from Baylor College of Medicine have made significant discoveries in understanding the molecular mechanisms underlying breast cancer metastasis. The study, published in Molecular Cancer Research, suggests that the heparanase (HPSE)-human epidermal growth factor receptor 2 (HER2)/epidermal growth factor receptor (EGFR) axis plays a critical role in augmenting
Drugs
Scientists at Duquesne University's Pharmaceutical Sciences Division have designed, synthesized, and evaluated two novel compounds that have shown promise in cancer treatment. These single agents, which combine antiangiogenic and cytotoxic effects, have been tested in a mouse model and have demonstrated significant tumor growth inhibition, inhibition of metastasis,
Drugs
Researchers at the National Tsing-Hua University in Hsinchu, Taiwan, have made a groundbreaking discovery in the field of cancer treatment. By combining two existing anti-inflammatory drugs, troglitazone and aspirin, the team led by K.H. Yan has found that the resulting synergy can produce a strong anticancer effect, arresting cell
Cancer research
Cancer researchers at the Third Military Medical University's Cancer Center in Chongqing, People's Republic of China, have reported a breakthrough in cancer gene therapy by combining photodynamic therapy (PDT) with adenovirus-mediated apurinic /apyrimidinic endonuclease 1 (APE1) silencing. This innovative approach has shown promising results in treating
Cancer treatment
Lung cancer is a leading cause of cancer-related deaths worldwide, with most patients presenting with advanced disease and limited treatment options. Targeted therapies, such as erlotinib and gefitinib, have shown promise in inhibiting the epidermal growth factor receptor (EGFR) pathway, but only a fraction of patients respond to these agents,
Cancer treatment
Researchers in Singapore have made a significant breakthrough in cancer therapy by developing a novel approach that combines tissue-specific promoter and microRNA regulation to control the expression of a suicide gene in cancer cells. This study, published in Molecular Therapy, demonstrates the potential of this method to selectively target and
Cancer treatment
A recent study published in Nutrition Reviews suggests that a nutritional approach may play a beneficial role in skin cancer prevention. Researchers from Tel Aviv University found that nutrients such as antioxidant vitamins, minerals, and phytochemicals, in addition to n-3 polyunsaturated fatty acids, n-9 monounsaturated fatty acids, and low pro-inflammatory
